MedTrace Logo

Safety and Bioefficacy of Vitamin D2 and Vitamin D3

NCT01503216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2012-10-10

No results posted yet for this study

Summary

The aim of this study is to investigate the bioavailability of vitamin D2 and D3 as measured by the increase of the specific hydroxy forms in serum (25(OH)D2 and 25(OH)D3, respectively, and by total 25(OH)D.

Conditions

  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

cholecalciferol

cholecalciferol, 2000 IU per day, 8 weeks

DIETARY_SUPPLEMENT

ergocalciferol

vitamin d2, 2000 IU per day for 8 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Ulrike Lehmann

    lead OTHER

Principal Investigators

  • Jutta Dierkes, Prof. Dr. · Institut für Agrar- und Ernährungswissenschaften

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-05-31
Completion
2012-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01503216 on ClinicalTrials.gov